ImmuneOncia Therapeutics

ImmuneOncia Therapeutics, Inc. is a biopharmaceutical company focused on immuno-oncology. Established in 2016 as a joint venture between Yuhan (51%) and Sorrento (49%), its mission is to provide safe, effective, and innovative immunotherapies for cancer patients worldwide.Yuhan Corporation is a healthcare company headquartered in South Korea, founded in 1926. In terms of market value and sales revenue in South Korea, the company ranks among the top pharmaceutical companies. Its core businesses include primary and specialty care, dietary supplements, home and animal care, as well as contract manufacturing of active pharmaceutical ingredients.Sorrento is an antibody-focused clinical-stage biopharmaceutical company developing novel approaches for treating cancer, inflammation, and autoimmune diseases. Sorrento's leading products include multiple late-stage biosimilars and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.